Click here to go to the previous page
The Management of Prostate Cancer
Program Code:
020
Date:
Friday, March 22, 2013
SPEAKER(S):
Michael J. Zelefsky, MD, FASTRO
Stanley Liauw, MD
Description
The goals of this session are to review major evidence which defines the role of radiation therapy for prostate cancer and review key factors which influence treatment outcome regarding disease and toxicity of therapy. The session will cover early risk prostate cancer (intact, low and intermediate risk) and locally advanced prostate cancer (intact, high risk and post-operative adjuvant or salvage therapy).